# Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)

> **NCT00240877** · PHASE3 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 330 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** AV024
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00240877
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2003-08
- **Final completion:** 2004-04
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2008-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00240877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00240877, "Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00240877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*